Metropolitan Life Insurance Company (MetLife)’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,269
Closed -$137K 436
2024
Q1
$137K Buy
3,269
+538
+20% +$22.6K 0.01% 886
2023
Q4
$108K Hold
2,731
0.01% 1034
2023
Q3
$75.2K Buy
2,731
+188
+7% +$5.17K ﹤0.01% 1171
2023
Q2
$86.3K Hold
2,543
﹤0.01% 1097
2023
Q1
$91.5K Sell
2,543
-290
-10% -$10.4K ﹤0.01% 1031
2022
Q4
$126K Sell
2,833
-163
-5% -$7.27K 0.01% 931
2022
Q3
$84.2K Hold
2,996
﹤0.01% 1119
2022
Q2
$80.8K Hold
2,996
﹤0.01% 1193
2022
Q1
$102K Sell
2,996
-9,152
-75% -$312K ﹤0.01% 1176
2021
Q4
$469K Hold
12,148
0.01% 1480
2021
Q3
$656K Buy
12,148
+1,041
+9% +$56.2K 0.01% 1270
2021
Q2
$371K Buy
+11,107
New +$371K 0.01% 1712
2018
Q2
Sell
-2,348
Closed -$82K 2458
2018
Q1
$82K Sell
2,348
-426
-15% -$14.9K ﹤0.01% 2376
2017
Q4
$118K Sell
2,774
-1,548
-36% -$65.8K ﹤0.01% 2215
2017
Q3
$185K Sell
4,322
-388
-8% -$16.6K ﹤0.01% 2314
2017
Q2
$175K Hold
4,710
﹤0.01% 2415
2017
Q1
$255K Buy
4,710
+446
+10% +$24.1K ﹤0.01% 2110
2016
Q4
$226K Sell
4,264
-492
-10% -$26.1K ﹤0.01% 2277
2016
Q3
$288K Buy
4,756
+29
+0.6% +$1.76K ﹤0.01% 2093
2016
Q2
$311K Hold
4,727
﹤0.01% 2013
2016
Q1
$268K Buy
4,727
+94
+2% +$5.33K ﹤0.01% 1980
2015
Q4
$1.09M Sell
4,633
-126
-3% -$29.6K 0.01% 1142
2015
Q3
$752K Hold
4,759
0.01% 1351
2015
Q2
$1.8M Sell
4,759
-247
-5% -$93.4K 0.01% 1007
2015
Q1
$2.09M Buy
5,006
+221
+5% +$92.4K 0.02% 885
2014
Q4
$1.31M Hold
4,785
0.01% 1167
2014
Q3
$930K Hold
4,785
0.01% 1323
2014
Q2
$1.17M Hold
4,785
0.01% 1255
2014
Q1
$1.27M Hold
4,785
0.01% 1188
2013
Q4
$1.74M Buy
4,785
+539
+13% +$196K 0.01% 1041
2013
Q3
$2.26M Sell
4,246
-269
-6% -$143K 0.02% 865
2013
Q2
$1.06M Buy
+4,515
New +$1.06M 0.01% 1197